Trochleoplasty in the Management of Objective Patellar Instability: a Personalized Surgical Approach for the Prevention of Recurrence in Patients With Trochlear Dysplasia (TROCHLEO-CARE)
This is a multicentre, international, non-profit observational study aimed at prospectively validating a personalized diagnostic and therapeutic algorithm based on the Dejour v3.0 classification in patients with recurrent objective patellar instability and trochlear dysplasia.
The primary objective is to compare treatment failure rates at 24 months between patients with severe trochlear dysplasia (trochlear bump >5 mm) treated with trochleoplasty and MPFL reconstruction, and a retrospective control group with similar trochlear morphology treated without trochleoplasty.
Secondary outcomes include clinical and functional outcomes assessed using validated scores (IKDC, Kujala, Tegner and BPII 2.0), cartilage status assessed by MRI using the MOAKS score, and postoperative complications, particularly arthrofibrosis.
Patients aged 14-49 years will be enrolled at IRCCS Istituto Ortopedico Rizzoli and Lyon Ortho Clinic. The study includes both a prospective cohort managed according to the Dejour v3.0 algorithm and a retrospective historical control cohort. Follow-up assessments will be performed up to 24 months after surgery.
The study is planned to start on October 1, 2026, with an expected completion date of September 30, 2029. A total sample size of 152 patients (76 per group) is planned.
연구 개요
상태
상태
정황
정황
연구 유형
연구 유형
등록 (추정된)
등록
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Stefano Zaffagnini
- 전화번호: 0516366075
- 이메일: stefano.zaffagnini@ior.it
연구 장소
-
-
Bologna
-
Bologna, Bologna, 이탈리아, 40136
- IRCCS Rizzoli Orthopedic Institute
-
연락하다:
- Stefano Zaffagnini
- 전화번호: 0516366075
- 이메일: stefano.zaffagnini@ior.it
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
The study will be conducted within the facilities of the Orthopedic and Traumatology Clinic II Unit at the IRCCS Istituto Ortopedico Rizzoli and at the Lyon Ortho Clinic. Surgical procedures will be performed at both these institutions.
Patients will be asked to sign an informed consent during the hospital stay and after signing the informed consent will be asked to complete a questionnaire on the preoperative condition.
Clinical follow-up visits will be carried out at the outpatient clinics of the IRCCS Istituto Ortopedico Rizzoli as well as at the Lyon Ortho Clinic.
설명
Inclusion Criteria study group:
- Patients aged ≥14 years and <50 years
- Male and female patients
- Patients with a clinical history of recurrent objective patellar instability (OPI)
- Provision of written informed consent to participate in the study
- Patients who performed preoperative imaging studies (MRI) that confirmed the diagnosis and the need for treatment based on the above mentioned criteria (type 3 dysplasia with a bump >5mm)
Exclusion Criteria study group:
- Patients with established knee osteoarthritis (K-L ≥2)
- Patients with concomitant ligament injuries (including anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), or collateral ligaments)
- Patients with a history of prior knee surgery for conditions other than patellar instability
- Patients who have previously undergone surgical procedures for patellar instability (OPI)
- Patients with incomplete or inadequate MRI data
Inclusion Criteria control group:
- Patients aged ≥14 years and <50 years treated for OPI with another procedure except trochleoplasty in the two reference centres from 2022 to 2024
- Male and female patients
- Provision of written informed consent to participate in the study
- Patients who performed preoperative imaging studies (MRI/CT scan) that confirmed a type 3 dysplasia with a bump >5mm
Exclusion Criteria control group:
- Patients with concomitant ligament injuries (including anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), or collateral ligaments)
- Patients with a history of prior knee surgery for conditions other than patellar instability
- Patients who have had previously undergone surgical procedures for patellar instability (OPI) at the time of the MRI/CT scan
- Patients with incomplete or inadequate MRI or CT scan data
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: CASE_CONTROL
- 시간 관점: PROSPECTIVE
그룹/코호트 수
코호트 및 개입
그룹/코호트그룹/코호트 |
|---|
|
Case group
Patients who performed preoperative imaging studies (MRI) that confirmed the diagnosis and the need for treatment based on the above mentioned criteria (type 3 dysplasia with a bump >5mm). They are treated according to the Dejour v3.0 algorithm, which involves trochleoplasty combined with medial patellofemoral ligament (MPFL) reconstruction. |
|
Control group
The control group includes patients with comparable anatomical characteristics who were previously treated without trochleoplasty. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Failure rates
기간: At 24 months
|
Defined as reoperation for subsequent atraumatic patellar luxation or persistent instability at 24 months. They will be registered in the CRF during the follow-up visits or during the telephonic contact in case of missing follow-ups. This could also be assessed through the clinical documentation of the patient, in case of missing data. |
At 24 months
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- TROCHLEO-CARE
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .